EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validation of the Global Treatment Burden Question (GTBQ): A novel single-item measure for use in clinical and research settings

Chloe Gamlin iD, Rachel Johnson, Lauren J Scott, Anastasiia Kovalenko iD, Rebecca Goulding iD, Thomas Brain, Simon Chilcott, Thomas Blakeman, Jose M Valderas, Simon D S Fraser iD, Polly Duncan iD

Journal of Multimorbidity and Comorbidity · 2026-05 · 16

DOI: 10.1177/26335565261443779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Multimorbidity and Comorbidity, online erschienen am 02.05.2026. Verfasst von Chloe Gamlin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Academic Primary Care, University of Bristol, Bristol, UK. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South West GP Trust, NIHR School for Primary Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A single-item, global measure could be valuable for identifying patients with high treatment burden within clinical practice and research.

Aim

To validate a novel single-item global measure, named the ‘Global Treatment Burden Question’ (GTBQ).

Methods

GTBQ: “how hard have you found the work of looking after your health conditions?” (responses “not hard”, “slightly hard”, “moderately hard”, “very hard”, “extremely hard”). Included participants: 18-65 years, ≥2 long-term conditions. Baseline survey: GTBQ, socio-demographics, Multimorbidity Treatment Burden Questionnaire (MTBQ), quality of life, health literacy. Follow-up survey: GTBQ. Electronic health records data: long-term conditions, consultations. Spearman’s Rank correlation (R s ) and intraclass correlation coefficient (ICC) assessed construct validity and test-retest reliability. GTBQ performance was examined against global MTBQ scores to determine optimal thresholds.

Results

974 (mean age 51) and 97 participants returned baseline and follow-up surveys, respectively. Responses were positively skewed with 22% reporting no burden at baseline. GTBQ scores were positively associated with global MTBQ scores (R s 0.70); weakly associated with health literacy (R s 0.36) and healthcare use (R s 0.27); and negatively associated with physical health (R s –0.66) and mental health (R s –0.65). ICC was 0.66. GTBQ demonstrated excellent ability to discriminate between high and non-high treatment burden (area under the curve 0.838). Applying a GTBQ threshold of ≥3 yielded specificity 90%, sensitivity 53%, positive-predictive-value 82%, and negative-predictive-value 69%, indicating utility in ‘ruling in’ high treatment burden.

Conclusion

This novel single-item measure has demonstrated good content and construct validity, moderate test-retest reliability, and strong ability to discriminate between high and non-high treatment burden.

Schlagwörter

Stichwörter der Autor:innen

multimorbiditytreatment burdenvalidation

Autor:innen und Institutionen

  • Centre for Academic Primary Care, University of Bristol, Bristol, UK.
  • National Institute for Health Research Applied Research Collaboration West (NIHR ARC West), University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
  • Centre for Primary Care and Health Services Research, The University of Manchester, Manchester, UK.
  • Exeter Collaboration for Academic Primary Care, University of Exeter, Exeter, UK.

ORCID-Profile: Chloe Gamlin, Anastasiia Kovalenko, Rebecca Goulding, Simon D S Fraser, Polly Duncan

Förderung

  • South West GP Trust
  • NIHR School for Primary Care Research

Zitieren

APA

Gamlin, C., Johnson, R., Scott, L. J., Kovalenko, A., Goulding, R., Brain, T., Chilcott, S., Blakeman, T., Valderas, J. M., Fraser, S. D. S., & Duncan, P. (2026). Validation of the Global Treatment Burden Question (GTBQ): A novel single-item measure for use in clinical and research settings. Journal of Multimorbidity and Comorbidity, 16. https://doi.org/10.1177/26335565261443779

Vancouver

Gamlin C, Johnson R, Scott LJ, Kovalenko A, Goulding R, Brain T, et al. Validation of the Global Treatment Burden Question (GTBQ): A novel single-item measure for use in clinical and research settings. Journal of Multimorbidity and Comorbidity. 2026;16. doi:10.1177/26335565261443779

BibTeX
@article{Gamlin2026,
  author = {Gamlin, Chloe and Johnson, Rachel and Scott, Lauren J and Kovalenko, Anastasiia and Goulding, Rebecca and Brain, Thomas and Chilcott, Simon and Blakeman, Thomas and Valderas, Jose M and Fraser, Simon D S and Duncan, Polly},
  title = {Validation of the Global Treatment Burden Question (GTBQ): A novel single-item measure for use in clinical and research settings},
  journal = {Journal of Multimorbidity and Comorbidity},
  year = {2026},
  volume = {16},
  doi = {10.1177/26335565261443779}
}
Kostenlos starten →